These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 34814322)
21. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
22. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma. Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H Front Immunol; 2023; 14():1111494. PubMed ID: 36817451 [TBL] [Abstract][Full Text] [Related]
23. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study. Ping G; Tian Y; Zhou Z Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426 [TBL] [Abstract][Full Text] [Related]
24. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma. Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K Front Oncol; 2022; 12():904464. PubMed ID: 35912258 [TBL] [Abstract][Full Text] [Related]
25. Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients. Li Z; Liu Y; Lin B; Yan W; Yi H; Wang H; Wei Y Front Genet; 2022; 13():925338. PubMed ID: 35937993 [No Abstract] [Full Text] [Related]
26. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma. Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583 [TBL] [Abstract][Full Text] [Related]
27. Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study. Pan Z; Li Q; Feng Y; Gao C; Pan F Medicine (Baltimore); 2022 Sep; 101(39):e30758. PubMed ID: 36181098 [TBL] [Abstract][Full Text] [Related]
28. A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Zhang B; Wang Z Front Mol Biosci; 2022; 9():890215. PubMed ID: 36262473 [No Abstract] [Full Text] [Related]
29. Effect of Pyroptosis-Related Genes on the Prognosis of Breast Cancer. Zhou Y; Zheng J; Bai M; Gao Y; Lin N Front Oncol; 2022; 12():948169. PubMed ID: 35957895 [TBL] [Abstract][Full Text] [Related]
30. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer. Liu J; Yu F; Liu Z; Wang X; Li J Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265 [No Abstract] [Full Text] [Related]
31. Construction of a PANoptosis-related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Ovarian Cancer. Liu Y; Lyu G Curr Med Chem; 2024 Sep; ():. PubMed ID: 39248067 [TBL] [Abstract][Full Text] [Related]
32. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma. Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176 [TBL] [Abstract][Full Text] [Related]
33. Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer. Zhao J; Wu C; Wang Y; Li M; Jiang Y; Luo Y Transl Cancer Res; 2022 Jul; 11(7):1865-1879. PubMed ID: 35966309 [TBL] [Abstract][Full Text] [Related]
34. The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma. Chen W; Cheng J; Cai Y; Wang P; Jin J Open Med (Wars); 2024; 19(1):20230886. PubMed ID: 38221934 [TBL] [Abstract][Full Text] [Related]
35. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma. Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070 [TBL] [Abstract][Full Text] [Related]
36. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature. Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528 [TBL] [Abstract][Full Text] [Related]
37. Identification of Key Pyroptosis-Related Genes and Distinct Pyroptosis-Related Clusters in Periodontitis. Ning W; Acharya A; Li S; Schmalz G; Huang S Front Immunol; 2022; 13():862049. PubMed ID: 35844512 [TBL] [Abstract][Full Text] [Related]
38. The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma. Gao J; Wang D; Yang Q; Tang M; Du J; He L; Liu W Front Mol Biosci; 2023; 10():1131402. PubMed ID: 36911522 [TBL] [Abstract][Full Text] [Related]
39. Expression of pyroptosis-related genes are correlated with immune microenvironment and predict prognosis in ESCA. Shi Y; Yang Q; Tai G; Chen X J Cancer Res Clin Oncol; 2023 Sep; 149(12):10701-10713. PubMed ID: 37302999 [TBL] [Abstract][Full Text] [Related]
40. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas. He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]